The novelty-seeking phenotype modulates the long-lasting effects of adolescent MDMA exposure

Physiology and Behavior

Volumn 141, Issue , 2015, Pages 190-198

  Rodríguez Arias, Marta ^a   Vaccaro, Sonia ^a   Arenas, M Carmen ^a   Aguilar, María A ^a   Miñarro, José ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Adolescence; Cocaine; CPP; MDMA; Mice; Novelty seeking

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; COCAINE; DOPAMINE; SEROTONIN; ADRENERGIC RECEPTOR AFFECTING AGENT;

ADOLESCENT; AGGRESSION; ANIMAL EXPERIMENT; ARTICLE; CONDITIONED PLACE PREFERENCE TEST; CORPUS STRIATUM; DRUG SEEKING BEHAVIOR; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; PHENOTYPE; PLACE PREFERENCE; PRIORITY JOURNAL; SOCIAL BEHAVIOR; SOCIAL INTERACTION TEST; TRANQUILIZING ACTIVITY; ANIMAL; ANIMAL BEHAVIOR; DRUG EFFECTS; EXPLORATORY BEHAVIOR; INSTRUMENTAL CONDITIONING; LEARNING; PHYSIOLOGY;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ASSOCIATION LEARNING; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; EXPLORATORY BEHAVIOR; MALE; MICE; MOTOR ACTIVITY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PHENOTYPE; SOCIAL BEHAVIOR;

EID: 84921837081     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2015.01.023     Document Type: Article

References (79)

1. EMCDDA-European Monitoring Centre for Drugs and Drug Addiction European Drug Report: Trends and Developments 2014, Publications Office of the European Union, Luxembourg. 10.2810/32306.
2. Cami J., Farré M., Mas M., Roset P.N., Poudevida S., Mas A., San L., de la Torre R. Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects. J. Clin. Psychopharmacol. 2000, 20:455-466.
3. Parrott A.C., Gibbs A., Scholey A.B., King R., Owens K., Swann P., Ogden E., Stough C. MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study. Psychopharmacology (Berl) 2011, 215:527-536. 10.1007/s00213-011-2184-9.
4. Parrott A.C. Human psychobiology of MDMA or 'Ecstasy': an overview of 25years of empirical research. Hum. Psychopharmacol. 2013, 28(4):289-307. 10.1002/hup.2318.
5. Lamb R.J., Griffiths R.R. Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboon. Psychopharmacology (Berl) 1987, 91(3):268-272.
6. Fantegrossi W.E., Ullrich T., Rice K.C., Woods J.H., Winger G. 3,4-Methy-lenedioxymethamphetamine (MDMA, ecstasy) and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement. Psychopharmacology (Berl) 2002, 4:356-364.
7. Trigo J.M., Panayi F., Soria G., Maldonado R., Robledo P. A reliable model of intravenous MDMA self-administration in naïve mice. Psychopharmacology (Berl) 2006, 184:212-220.
8. Touriño C., Ledent C., Maldonado R., Valverde O. CB1 cannabinoid receptor modulates 3,4-methylenedioxymethamphetamine acute responses and reinforcement. Biol. Psychiatry 2008, 63:1030-1038.
9. Bilsky E.J., Reid L.D. MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference. Pharmacol. Biochem. Behav. 1991, 2:509-512.
10. Catlow B.J., Badanich K.A., Sponaugle A.E., Rowe A.R., Song S., Rafalovich I., Sava V., Kirstein C.L., Sanchez-Ramos J. Effects of MDMA ("ecstasy") during adolescence on place conditioning and hippocampal neurogenesis. Eur. J. Pharmacol. 2010, 628(1-3):96-103. 10.1016/j.ejphar.2009.11.017.
11. Daza-Losada M., Ribeiro Do Couto B., Manzanedo C., Aguilar M.A., Rodriíguez-Arias M., Miñarro J. Rewarding effects and reinstatement of MDMA-induced CPP in adolescent mice. Neuropsychopharmacology 2007, 32:1750-1759. 10.1038/sj.npp.1301309.
12. Vidal-Infer A., Roger-Sánchez C., Daza-Losada M., Aguilar M.A., Miñarro J., Rodríguez-Arias M. Role of the dopaminergic system in the acquisition, expression and reinstatement of MDMA-induced conditioned place preference in adolescent mice. PLoS One 2012, 7(8):e43107. 10.1371/journal.pone.0043107.
13. Rodríguez-Arias M., Valverde O., Daza-Losada M., Blanco-Gandía M.C., Aguilar M.A., Miñarro J. Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: role of CB1 receptors. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 47:77-84. 10.1016/j.pnpbp.2013.07.013.
14. Roger-Sánchez C., Rodríguez-Arias M., Miñarro J., Aguilar M.A. Involvement of 5-hydroxytryptamine5-HT3 serotonergic receptors in the acquisition and reinstatement of the conditioned place preference induced by MDMA. Eur. J. Pharmacol. 2013, 714:132-141. 10.1016/j.ejphar.2013.06.005.
15. Gerra G., Zaimovic A., Giucastro G., Maestri D., Monica C., Sartori R., Caccavari R., Delsignore R. Serotonergic function after (+/-)3,4-methylene-dioxymethamphetamine ('Ecstasy') in humans. Int. Clin. Psychopharmacol. 1998, 13(1):1-9.
16. Fone K.C., Beckett S.R., Topham I.A., Swettenham J., Ball M., Maddocks L. Long term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity. Psychopharmacology (Berl) 2002, 159:437-444.
17. Morley-Fletcher S., Bianchi M., Gerra G., Laviola G. Acute and carryover effects in mice of MDMA ("ecstasy") administration during periadolescence. Eur. J. Pharmacol. 2002, 448(1):31-38.
18. Balogh B., Molnar E., Jakus R., Quate L., Olverman H.J., Kelly P.A., Kantor S., Bagdy G. Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA. Psychopharmacology (Berl) 2004, 173(3-4):296-309.
19. Mechan A.O., Moran P.M., Elliott M., Young A.J., Joseph M.H., Green R. A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field. Psychopharmacology (Berl) 2002, 159:167-175.
20. Ho Y.J., Pawlak C.R., Guo L., Schwarting R.K. Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat. Behav. Brain Res. 2004, 149:135-144.
21. Faria R., Magalhães A., Monteiro P.R., Gomes-Da-Silva J., Amélia Tavares M., Summavielle T. MDMA in adolescent male rats: decreased serotonin in the amygdala and behavioral effects in the elevated plus-maze test. Ann. N. Y. Acad. Sci. 2006, 1074:643-649.
22. Clemens K.J., McGregor I.S., Hunt G.E., Cornish J.L. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research. Drug Alcohol Rev. 2007, 26(1):9-15.
23. Daza-Losada M., Rodríguez-Arias M., Maldonado C., Aguilar M.A., Miñarro J. Behavioural and neurotoxic long-lasting effects of MDMA plus cocaine in adolescent mice. Eur. J. Pharmacol. 2008, 590(1-3):204-211. 10.1016/j.ejphar.2008.06.025.
24. Rodríguez-Arias M., Maldonado C., Vidal-Infer A., Guerri C., Aguilar M.A., Miñarro J. Intermittent ethanol exposure increases long-lasting behavioral and neurochemical effects of MDMA in adolescent mice. Psychopharmacology (Berl) 2011, 218(2):429-442. 10.1007/s00213-011-2329-x.
25. Achat-Mendes C., Anderson K.L., Itzhak Y. Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood. Neuropharmacology 2003, 45(1):106-115. 10.1016/S0028-3908(03)00135-7.
26. Cole J.C., Sumnall H.R., O'Shea E., Marsden C.A. Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse. Psychopharmacology (Berl) 2003, 166(4):383-390. 10.1007/s00213-002-1374-x.
27. Horan B., Gardner E.L., Ashby C.R. Enhancement of conditioned place preference response to cocaine in rats following subchronic administration of 3, 4-methylenedioxymethamphetamine (MDMA). Synapse 2000, 35:160-162. 10.1002/(SICI)1098-2396(200002)35:2<160::AID-SYN9>3.0.CO;2-O.
28. Morgan A.E., Horan B., Dewey S.L., Ashby C.R. Repeated administration of 3,4-methylenedioxymethamphetamine augments cocaine's action on dopamine in the nucleus accumbens: a microdialysis study. Eur. J. Pharmacol. 1997, 331:R1-R3. 10.1016/S0014-2999(97)01035-2.
29. Daza-Losada M., Rodríguez-Arias M., Aguilar M.A., Miñarro J. Acquisition and reinstatement of MDMA-induced conditioned place preference in mice pre-treated with MDMA or cocaine during adolescence. Addict. Biol. 2009, 14(4):447-456. 10.1111/j.1369-1600.2009.00173.x.
30. Milivojevic D., Milovanovic S.D., Jovanovic M., Svrakic D.M., Svrakic N.M., Svrakic S.M., Cloninger C.R. Temperament and character modify risk of drug addiction and influence choice of drugs. Am. J. Addict. 2012, 21(5):462-467. 10.1111/j.1521-0391.2012.00251.x.
31. Kelley A.E., Schochet T., Landry C.F. Risk taking and novelty seeking in adolescence: introduction to part I. Ann. N. Y. Acad. Sci. 2004, 1021:27-32.
32. Staiger P.K., Kambouropoulos N., Dawe S. Should personality traits be considered when refining substance misuse treatment programs?. Drug Alcohol Rev. 2007, 26(1):17-23.
33. Ballaz S.J., Akil H., Watson S.J. The 5-HT7 receptor: role in novel object discrimination and relation to novelty-seeking behavior. Neuroscience 2007, 149:192-202. 10.1016/j.neuroscience.2007.07.043.
34. Alemany R.Nadal Novelty-seeking: its relationship with vulnerability to addiction and stress. Adicciones 2008, 20(1):59-72.
35. Belin D., Berson N., Balado E., Piazza P.V., Deroche-Gamonet V. High-novelty-preference rats are predisposed to compulsive cocaine self-administration. Neuropsychopharmacology 2011, 36(3):569-579. 10.1038/npp.2010.188.
36. Vidal-Infer A., Arenas M.C., Daza-Losada M., Aguilar M.A., Miñarro J., Rodríguez-Arias M. High novelty-seeking predicts greater sensitivity to the conditioned rewarding effects of cocaine. Pharmacol. Biochem. Behav. 2012, 102(1):124-132. 10.1016/j.pbb.2012.03.031.
37. Arenas M.C., Daza-Losada M., Vidal-Infer A., Aguilar M.A., Miñarro J., Rodríguez-Arias M. Capacity of novelty-induced locomotor activity and the hole-board test to predict sensitivity to the conditioned rewarding effects of cocaine. Physiol. Behav. 2014, 133:152-160. 10.1016/j.physbeh.2014.05.028.
38. Mateos-García A., Roger-Sánchez C., Rodriguez-Arias M., Miñarro J., Aguilar M.A., Manzanedo C., Arenas M.C. Higher sensitivity to the conditioned rewarding effects of cocaine and MDMA in High-Novelty-Seekers mice exposed to a cocaine binge during adolescence. Psychopharmacology (Berl) 2015, 232:101-113. 10.1007/s00213-014-3642-y.
39. Montagud-Romero S., Daza-Losada M., Vidal-Infer A., Maldonado C., Aguilar M.A., Miñarro J., Rodríguez-Arias M. The novelty-seeking phenotype modulates the long-lasting effects of intermittent ethanol administration during adolescence. PLoS One 2014, 9(3):e92576. 10.1371/journal.pone.0092576.
40. Bird J., Schenk S. Contribution of impulsivity and novelty-seeking to the acquisition and maintenance of MDMA self-administration. Addict. Biol. 2013, 18:654-664. 10.1111/j.1369-1600.2012.00477.x.
41. Maldonado C., Rodriguez-Arias M., Castillo A., Aguilar M.A., Minarro J. Gamma-hydroxybutyric acid affects the acquisition and reinstatement of cocaine-induced conditioned place preference in mice. Behav. Pharmacol. 2006, 17:119-131.
42. Manzanedo C., Rodríguez-Arias M., Daza-Losada M., Maldonado C., Aguilar M.A., Miñarro J. Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice. Behav. Brain Funct. 2010, 6:19. 10.1186/1744-9081-6-19.
43. Rodríguez-Arias M., Manzanedo C., Roger-Sánchez C., Do Couto B.R., Aguilar M.A., Miñarro J. Effect of adolescent exposure to WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34(1):166-171. 10.1016/j.pnpbp.2009.10.019.
44. Calabrese E.J. An assessment of anxiolytic drug screening tests: hormetic dose responses predominate. Crit. Rev. Toxicol. 2008, 38(6):489-542. 10.1080/10408440802014238.
45. Kliethermes C.L., Kamens H.M., Crabbe J.C. Drug reward and intake in lines of mice selectively bred for divergent exploration of a hole board apparatus. Genes Brain Behav. 2007, 6(7):608-618.
46. Pellow S., File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol. Biochem. Behav. 1986, 24(3):525-529.
47. Rodgers R.J., Cao B.J., Dalvi A., Holmes A. Animal models of anxiety: an ethological perspective. Braz. J. Med. Biol. Res. 1997, 30(3):289-304.
48. Smoothy R., Brain P.F., Berry M.S., Haug M. Alcohol and social behavior in group-housed female mice. Physiol. Behav. 1986, 37:689-694.
49. Brain P.F., Benton D., Childs G., Parmigiani S. The effect of the type of opponent in test of murine aggression. Behav. Processes 1981, 6:319-327.
50. Mugford R.A., Nowell N.W. Pheromones and their effect on aggression in mice. Nature 1970, 226:967-968.
51. Rodríguez-Arias M., Miñarro J., Aguilar M.A., Pinazo J., Simón V.M. Effects of risperidone and SCH 23390 on isolation-induced aggression in male mice. Eur. Neuropsychopharmacol. 1998, 8:95-103. 10.1016/S0924-977X(97)00051-5.
52. Hughes R.N. Neotic preferences in laboratory rodents: Issues, assessment and substrates. Neurosci. Biobehav. Rev. 2007, 31:441-464. 10.1016/j.neubiorev.2006.11.004.
53. Dickson P.E., Ndukum J., Wilcox T., Clark J., Roy B., Zhang L., Li Y., Lin D.T., Chesler E.J. Association of novelty-related behaviors and intravenous cocaine self-administration in Diversity Outbred mice. Psychopharmacology Sep 20 2014, (Berl). 10.1007/s00213-014-3737-5.
54. Achat-Mendes C., Ali S.F., Itzhak Y. Differential effects of amphetamines-induced neurotoxicity on appetitive and aversive Pavlovian conditioning in mice. Neuropsychopharmacology 2005, 30(6):1128-1137.
55. Åberg M., Wade D., Wall E., Izenwasser S. Effect of MDMA (ecstasy) on activity and cocaine conditioned place preference in adult and adolescent rats. Neurotoxicol. Teratol. 2007, 29:37-46. 10.1016/j.ntt.2006.09.002.
56. Starosciak A.K., Zakharova E., Stagg M., Matos J., Izenwasser S. Differential alteration of the effects of MDMA (ecstasy) on locomotor activity and cocaine conditioned place preference in male adolescent rats by social and environmental enrichment. Psychopharmacology (Berl) 2012, 224(1):101-108. 10.1007/s00213-012-2783-0.
57. Ribeiro Do Couto B., Daza-Losada M., Rodríguez-Arias M., Nadal R., Guerri C., Summavielle T., Miñarro J., Aguilar M.A. Adolescent pre-exposure to ethanol and 3,4-methylenedioxymethylamphetamine (MDMA) increases conditioned rewarding effects of MDMA and drug-induced reinstatement. Addict. Biol. 2012, 17(3):588-600. 10.1111/j.1369-1600.2011.00382.x.
58. Gurtman C.G., Morley K.C., Li K.M., Hunt G.E., McGregor I.S. Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion. Eur. J. Pharmacol. 2002, 446:89-96.
59. Walker Q.D., Williams C.N., Jotwani R.P., Waller S.T., Francis R., Kuhn C.M. Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats. Psychopharmacology (Berl) 2007, 189:435-445.
60. Sumnall H.R., O'Shea E., Marsden C.A., Cole J.C. The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus maze test. Pharmacol. Biochem. Behav. 2004, 77:805-814.
61. Cassel J.C., Riegert C., Rutz S., Koenig J., Rothmaier K., Cosquer B., Lazarus C., Birthelmer A., Jeltsch H., Jones B.C., Jackisch R. Ethanol, 3,4-methylenedioxymethamphetamine methylenedioxymethamphetamine (ecstasy) and their combination: long-term behavioral, neurochemical and neuropharmacological effects in the rat. Neuropsychopharmacology 2005, 30:1870-1882.
62. Piper B.J., Meyer J.S. Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period. Pharmacol. Biochem. Behav. 2004, 79(4):723-731. 10.1016/j.pbb.2004.10.001.
63. Piper B.J., Fraiman J.B., Meyer J.S. Repeated MDMA ("Ecstasy") exposure in adolescent male rats alters temperature regulation, spontaneous motor activity, attention, and serotonin transporter binding. Dev. Psychobiol. 2005, 47(2):145-157. 10.1002/dev.20085.
64. Wallinga A.E., ten Voorde A.M., de Boer S.F., Koolhaas J.M., Buwalda B. MDMA-induced serotonergic neurotoxicity enhances aggressiveness in low-but not high-aggressive rats. Eur. J. Pharmacol. 2009, 618:22-27. 10.1016/j.ejphar.2009.07.006.
65. Kirilly E., Benko A., Ferrington L., Ando R.D., Kelly P.A., Bagdy G. Acute and long-term effects of a single dose of MDMA on aggression in Dark Agouti rats. Int. J. Neuropsychopharmacol. 2006, 9:63-76. 10.1017/S146114570500581X.
66. Bull E.J., Hutson P.H., Fone K.C. Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity. Neuropharmacology 2004, 46(2):202-210.
67. Bull E.J., Hutson P.H., Fone K.C. Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT 2C receptor responsivity. Neuropharmacology 2003, 44(4):439-448.
68. Clemens K.J., Cornish J.L., Li K.M., Hunt G.E., McGregor I.S. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats. Neuropharmacology 2005, 49(2):195-207.
69. Clemens K.J., Van Nieuwenhuyzen P.S., Li K.M., Cornish J.L., Hunt G.E., McGregor I.S. MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat. Psychopharmacology (Berl) 2004, 173(3-4):318-325.
70. Easton N., Marsden C.A. Ecstasy: are animal data consistent between species and can they translate to humans?. J. Psychopharmacol. 2006, 20:194-210.
71. Colado M.I., Camarero J., Mechan A.O., Sanchez V., Esteban B., Elliott J.M., Green A.R. A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurons in mouse brain. Br. J. Pharmacol. 2001, 134(8):1711-1723.
72. O'Shea E., Esteban B., Camarero J., Green A.R., Colado M.I. Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain. Neuropharmacology 2001, 40(1):65-74.
73. Saadat K.S., Elliott J.M., Colado M.I., Green A.R. The acute and long-term neurotoxic effects of MDMA on marble burying behaviour in mice. J. Psychopharmacol. 2006, 20(2):264-271.
74. Marston H.M., Reid M.E., Lawrence J.A., Olverman H.J., Butcher S.P. Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat. Psychopharmacology (Berl) 1999, 144(1):67-76.
75. Broening H.W., Morford L.L., Inman-Wood S.L., Fukumura M., Vorhees C.V. 3,4-Methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development. J. Neurosci. 2001, 21(9):3228-3235.
76. Kankaanpää A., Meririnne E., Lillsunde P., Seppälä T. The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens. Pharmacol. Biochem. Behav. 1998, 59:1003-1009.
77. Bardo M.T., Donohew R.L., Harrington N.G. Psychobiology of novelty seeking and drug seeking behavior. Behav. Brain Res. 1996, 77:23-43.
78. Kerman I.A., Clinton S.M., Bedrosian T.A., Abraham A.D., Rosenthal D.T., Akil H., Watson S.J. High novelty-seeking predicts aggression and gene expression differences within defined serotonergic cell groups. Brain Res. 2011, 1419:34-45. 10.1016/j.brainres.2011.08.038.
79. Arendt M., Rosenberg R., Fjordback L., Brandholdt J., Foldager L., Sher L., Munk-Jørgensen P. Testing the self-medication hypothesis of depression and aggression in cannabis-dependent subjects. Psychol. Med. 2007, 37:935-945. 10.1017/S0033291706009688.